Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03470012 · ClinicalTrials.gov registry record · NA
Adhesive Tape Trauma Evaluation of a New Gentle Tape in Healthy Infant Subjects
A NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03470012: Completed NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal, sponsored by Solventum US.
NCT03470012 is a NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal that has completed, run by Solventum US. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03470012, a NA study of Skin (FLACC Scores of Test Subjects) After Tape Removal, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the relative gentleness of a new medical tape.
Primary Outcome
The Face, Legs, Activity, Cry, Consolability (FLACC) scale is a measurement used to assess pain for children Participants between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. Lower values represent lessening pain on the scale. At the 24 hour visit , a baseline FLACC score was recorded with the tape still in place. The tape was then removed and a FLACC score was recorded after removal
Conditions Studied
Interventions
- DEVICE Multi-Purpose Gentle Tape
Study Locations (1)
Pennsylvania
- cyberDERM, inc. - Broomall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2018-03-20 |
| Phase | NA |
What the finished NCT03470012 record still lists
NCT03470012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Skin (FLACC Scores of Test Subjects) After Tape Removal appearing as the primary indexed condition, and to 1 intervention - of which Multi-Purpose Gentle Tape is the first listed.
NCT03470012 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03470012 about?
NCT03470012 is a clinical study titled "Adhesive Tape Trauma Evaluation of a New Gentle Tape in Healthy Infant Subjects". The objective of this study is to determine the relative gentleness of a new medical tape.
What is the current status of trial NCT03470012?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-01-16. Estimated completion is 2018-03-20.
What conditions does trial NCT03470012 study?
This clinical trial studies the following conditions: Skin (FLACC Scores of Test Subjects) After Tape Removal.
What interventions are being tested in trial NCT03470012?
The interventions under investigation include: Multi-Purpose Gentle Tape (DEVICE).
Who is sponsoring clinical trial NCT03470012?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03470012 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03470012's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI